002755SZSE
🚨 Material Event

Announcement on Subsidiary Maribavir Tablets Obtaining Drug Registration Certificate

✨ AI Summary

Beijing Winsun Pharmaceutical Co., Ltd. announces its subsidiary Jiangsu Winsun Pharmaceutical Co., Ltd. has received a Drug Registration Certificate for Maribavir Tablets from the NMPA. This marks a significant expansion in the company's anti-infective pipeline, enhancing its competitiveness in the field and positively impacting future operations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 002755

Stock Abbreviation: Winsun

Announcement No.: 2026-015

Beijing Winsun Pharmaceutical Co., Ltd.

Announcement on Subsidiary Maribavir Tablets Obtaining Drug Registration Certificate

The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and are free from any false records, misleading statements, or material omissions.

Beijing Winsun Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company")'s wholly-owned subsidiary, Jiangsu Winsun Pharmaceutical Co., Ltd. (hereinafter referred to as the "Subsidiary"), recently received the Drug Registration Certificate for Maribavir Tablets (hereinafter referred to as the "Drug Registration Certificate") approved and issued by the National Medical Products Administration (hereinafter referred to as the "NMPA"), the relevant details are as follows:

I. Basic Information of the Drug

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.